Award
National Cancer Institute 5U01CA272610-04
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
Recipient
Columbia University Health Sciences, New York, NY
Award Amount
$967,866.00
Ceiling
$967,866.00
Awarded
August 15, 2025
Identifier
5U01CA272610-04
The award supports research to study tumor dependencies and drug resistance at the single-cell level, developing combination therapies and biomarkers for drug sensitivity in cancer treatment.
Description
This project focuses on the elucidation and pharmacological targeting of tumor dependencies at the single-cell level, aiming to improve therapeutic strategies against various malignancies, including pediatric tumors.